The Story of Helen Moss

When I first discovered my cancer, I very naively felt that I could be just like Bruce Willis' character in 'Die Hard' and that I would fight this cancer off and be victorious. However, the treatment pulled me down and 'fighting' or that mind set drained my energy.

Read the rest of Helen's story here.

Board of Trustees

Helen Moss, Managing Trustee
Carole Adrine
Gregory R. Bean, Esq
Rev. Dr. Joan Campbell
Barrie Cassileth, Ph.D.
Dale H. Cowan, MD, JD,
Ensign Cowell
Stanton L. Gerson, M.D.

Betty Ann Helms
Jim Moss, Esq
John Moss
Peter Osenar
Timothy Resor, E.A.
Stephen Sagar, MD
Michael Weiss, MD, PhD

Robert J Ronis, M.D., M.P.H.
Wulf Utian, MD

Trustees Emeriti

Nathan Berger, MD
Barbara Peterson Ruhlman

Click here to find out more about the painting

Memorial Sloan-Kettering Cancer Center

 

Stanton L. Gerson, M.D., PDF Print E-mail
Director of the Case Western Reserve University Comprehensive Cancer Center and Ireland Cancer Center of University Hospitals of Cleveland

Dr. Gerson has been with the Case School of Medicine and University Hospitals of Cleveland since 1983.  Since 1995, he also has been chief of the Division of Hematology/Oncology.  In 1997, he was named the Asa and Patricia Shiverick- Jane Shiverick (Tripp) Professor of Hematological Oncology and, in 2003, he became the founding director of the Ohio Wright Center for Stem Cell and Regenerative Medicine. 

Dr. Gerson has been active in the stem cell, hematologic malignancies and developmental therapeutics programs.  He has multiple NIH grants and more than 170 publications, 190 abstracts, 20 book chapters and seven patents in stem cells and drug discovery. His honors include invited membership in the American Association of Physicians, and the Malinkrodt Scholar award.  Dr. Gerson is co-editor of the textbook Cancer Gene Therapy and the new text, Clinical Hematology, to be published in 2005.  He serves on a number of Scientific Advisory Boards including the Fox Chase Cancer Center, the MD Anderson Cancer Center, the University of Minnesota Cancer Center and the Duke Cancer Center. Dr. Gerson has served as the Chair of the Experimental Therapeutics II and serves on the Program Project Study Section for the National Institutes of Health and on numerous other review bodies for the NIH. 

Dr. Gerson graduated in 1973 from Harvard College, magna cum laude, and in 1977 from Harvard Medical School, cum laude.  From 1977 to 1983, he performed his internship, residency and fellowship training at the Hospital of the University of Pennsylvania.   His research interests are in the areas of stem cells and DNA repair. These studies may predict stem cell diseases of aging and cancer.  His research has generated seven patents in the area of gene therapy and cancer drug development that have been licensed to three companies.

 

Our Sponsors and Partners

Search Our Site


Save the Date

October 2010- 10th Annual Public Speakers Series

More information to come, please check back regurlarly.